Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
3 hedge funds and large institutions have $114K invested in Bio Green Med Solution Inc Preferred Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
27% more capital invested
Capital invested by funds: $90K → $114K (+$24K)
0.44% more ownership
Funds ownership: 4.53% → 4.97% (+0.44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$9.46K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBA
1
Baker Bros. Advisors
New York
| $89K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $15K | +$6 | +1 | +0% |
|
|
3
Citigroup
New York
| $10K | +$9.46K | +1,481 | New |
|
BGMSP Hedge Fund Activity: Q2 2018 in Review
3 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q2 2018, worth a combined $114K — up 27% from $90K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BGMSP positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $9.46K.
- 3 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q2 2018, up from 2 in Q1 2018.
- Funds reported $114K of Bio Green Med Solution Inc Preferred Stock stock for Q2 2018, up 27% quarter-over-quarter.
- 1 fund opened new Bio Green Med Solution Inc Preferred Stock positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q2 2018 was Citigroup, an estimated $9.46K added.
Based on aggregated 13F filings for Q2 2018.